CompletedPhase 3

Role of Salbutamol and Furosemide in TTN

Pakistan100 participantsStarted 2016-11-01

Plain-language summary

to see the effects of slabutamol and IV furosemide in the treatment of transient tachypnea of newborn

Who can participate

Age range1 Hour – 7 Days

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * all newborn babies with clinically diagnosed TTN Exclusion Criteria: * babies less than 34 weeks babies with congenital malformations and CHD

What they're measuring

duration of oxygen requiremment in neonates having TTN.

Timeframe: upto 6 months

Trial details

NCT IDNCT03208894

SponsorArmed Forces Hospital, Pakistan

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-05-30

View on ClinicalTrials.gov More Transient Tachypnea of the Newborn trials